 sort of this whole precision medicine, precision psychiatry angle that we have all been talking about for the last decade. Well, thank you both so much for joining us. That's all the time we have for now. I'd like to thank my guest, Sarah McNamee, a trial participant researcher at McGill University and a licensed psychotherapist based in Montreal, Quebec, and Eiko Fried, a methodologist, psychologist, and associate professor at Leiden University in the Netherlands. Thank you both so much for joining us.